Skip to main content
Caplight Logo









CelVivo

CelVivo

Private
OdenseHealthcare & Life Scienceshttps://celvivo.com

Last Round

VC Round

May 12, 2025

Total Funding Raised

$2.52M

Company Overview

CelVivo operates in Healthcare & Life Sciences and is based in Odense. Its latest recorded funding round was a VC Round in May 2025.

CelVivo is a biotechnology company that develops 3D cell culture technology, including bioreactor systems like ClinoStar, to grow and maintain spheroids and organoids that mimic in vivo physiological conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CelVivo Comparables

Compare CelVivo with similar companies based on industry and business-model similarity.

CelVivo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synthecon, Inc.
84%
TissUse
81%
MIMETAS
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CelVivo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 12, 2025
GrantJan 17, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Søren Baisner Alnøe

COO

Executive Team

For institutional investors. Book with your work email.

CelVivo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 41% MoM.

  • Apr 18, 2026

    Monthly visitors increased 43% MoM, reaching 6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

CelVivo Filings

Explore SEC and related filing metadata, where available.

CelVivo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CelVivo's valuation, stock price, and market status.

Is CelVivo a public or private company?

CelVivo is a private company.

What is the current stock price of CelVivo?

CelVivo is a private company, so its shares have no public market price. Caplight tracks CelVivo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CelVivo worth (valuation)?

Valuation information for CelVivo is not publicly available.

Can I buy CelVivo stock?

CelVivo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CelVivo's last funding round?

CelVivo's most recent funding round was VC Round on May 12, 2025.

Who are the main investors in CelVivo?

Key investors in CelVivo include The Export and Investment Fund of Denmark.

Will CelVivo IPO soon?

No public IPO plans have been announced for CelVivo.

How can I track CelVivo secondary market activity?

Caplight tracks bids, offers, and trades in CelVivo's shares on secondary markets.

Firmographic Details

HeadquartersOdense
Employee Range29
Year Founded2014
Last FundingMay 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?